FSCNX
Price
$17.55
Change
+$0.02 (+0.11%)
Updated
Dec 11 closing price
Net Assets
4.85B
RLBAX
Price
$39.79
Change
+$0.08 (+0.20%)
Updated
Dec 11 closing price
Net Assets
269.37B
Interact to see
Advertisement

FSCNX vs RLBAX

Header iconFSCNX vs RLBAX Comparison
Open Charts FSCNX vs RLBAXBanner chart's image
Fidelity Advisor Asset Manager 60% C
Price$17.55
Change+$0.02 (+0.11%)
VolumeN/A
Net Assets4.85B
American Funds American Balanced R1
Price$39.79
Change+$0.08 (+0.20%)
VolumeN/A
Net Assets269.37B
FSCNX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
FSCNX vs. RLBAX commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSCNX is a Buy and RLBAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 269B vs. FSCNX (4.85B). RLBAX pays higher dividends than FSCNX: RLBAX (1.07) vs FSCNX (0.85). FSCNX was incepted earlier than RLBAX: FSCNX (18 years) vs RLBAX (24 years). FSCNX (1.69) is less costly to investors than RLBAX (1.31). RLBAX is a more actively managed with annual turnover of: 44.00 vs. FSCNX (17.00). FSCNX has a lower initial minimum investment than RLBAX: FSCNX (0) vs RLBAX (250). RLBAX (10.19) and FSCNX (10.00) have marching annual gain over last year. RLBAX return over 5 years is better than : 36.12 vs. FSCNX (25.92).
FSCNXRLBAXFSCNX / RLBAX
Total Expense Ratio1.691.31129%
Annual Report Gross Expense Ratio1.691.31129%
Fund Existence18 years24 years-
Gain YTD15.25317.16389%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets4.85B269B2%
Annual Yield % from dividends0.851.0780%
Returns for 1 year10.0010.1998%
Returns for 3 years34.2441.6882%
Returns for 5 years25.9236.1272%
Returns for 10 years75.6172.33105%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTRP4.200.40
+10.53%
NextTrip
DVA118.682.01
+1.72%
DaVita
RANGU11.00N/A
N/A
Range Capital Acquisition Corp
AMRC31.66-0.64
-1.98%
Ameresco
AVXL4.08-0.33
-7.48%
Anavex Life Sciences Corp